Caplin Point Laboratories Limited

BSE:524742 Stok Raporu

Piyasa değeri: ₹149.4b

Caplin Point Laboratories Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 6/6

Caplin Point Laboratories has been growing earnings at an average annual rate of 18.9%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 16.9% per year. Caplin Point Laboratories's return on equity is 20.5%, and it has net margins of 27.2%.

Anahtar bilgiler

18.9%

Kazanç büyüme oranı

18.9%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı16.9%
Özkaynak getirisi20.5%
Net Marj27.2%
Sonraki Kazanç Güncellemesi07 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Caplin Point Laboratories nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:524742 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2417,5774,7761,4870
31 Mar 2416,9614,5711,437737
31 Dec 2316,3184,3761,430632
30 Sep 2315,6834,1791,408632
30 Jun 2315,1573,9471,3960
31 Mar 2314,6833,7631,371632
31 Dec 2214,1823,5321,314593
30 Sep 2213,7243,3071,262593
30 Jun 2213,1533,1401,2100
31 Mar 2212,7102,9981,154593
31 Dec 2112,0992,8721,110537
30 Sep 2111,5812,7671,071537
30 Jun 2111,2172,5861,0340
31 Mar 2110,6242,4231,026537
31 Dec 209,9862,248952530
30 Sep 209,5242,189874530
30 Jun 209,1072,1937800
31 Mar 208,6402,150678530
31 Dec 198,3562,159617282
30 Sep 197,6642,032557282
30 Jun 196,9481,8945120
31 Mar 196,4901,766471282
31 Dec 186,0481,621449237
30 Sep 185,8741,538431237
30 Jun 185,6281,4594170
31 Mar 185,3991,448391237
31 Dec 175,1451,430367141
30 Sep 174,7571,297352141
30 Jun 174,4011,1653220
31 Mar 174,016956321141
31 Dec 163,65578330054
30 Sep 163,42070327454
30 Jun 163,23861925854
31 Mar 163,08858424054
31 Dec 152,90653529867
30 Sep 152,72246528360
30 Jun 152,51841020359
31 Mar 152,29635323353
31 Dec 142,07431822042
30 Sep 141,89330520433
30 Jun 141,73125819021
31 Mar 141,6432041664
31 Dec 131,5171671490

Kaliteli Kazançlar: 524742 has high quality earnings.

Büyüyen Kar Marjı: 524742's current net profit margins (27.2%) are higher than last year (26%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 524742's earnings have grown by 18.9% per year over the past 5 years.

Büyüme Hızlandırma: 524742's earnings growth over the past year (21%) exceeds its 5-year average (18.9% per year).

Kazançlar vs. Sektör: 524742 earnings growth over the past year (21%) exceeded the Pharmaceuticals industry 19.1%.

Özkaynak Getirisi

Yüksek ROE: 524742's Return on Equity (20.5%) is considered high.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y